[New trends in immunotherapy of rheumatoid arthritis].
Todesco
S
S
Istituto di Medicina Interna, Università degli Studi di Padova.
Fiocco
U
U
Cozzi
L
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007378:Interleukins / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D051379:Mice; D051381:Rats; D013585:Synovitis / Q000209:etiology / Q000628:therapy
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007378:Interleukins; D003520:Cyclophosphamide; D008775:Methylprednisolone
Nuove prospettive nell'immunoterapia dell'artrite reumatoide.